APA (7th ed.) Citation

Schwartzberg LS, Lal LS, Balu S, Campbell K, Brekke L, Elliott C, & Korrer S. (2018). Incidence of febrile neutropenia during chemotherapy among patients with nonmyeloid cancer receiving filgrastim vs a filgrastim biosimilar. Dove Medical Press.

Chicago Style (17th ed.) Citation

Schwartzberg LS, Lal LS, Balu S, Campbell K, Brekke L, Elliott C, and Korrer S. Incidence of Febrile Neutropenia During Chemotherapy Among Patients with Nonmyeloid Cancer Receiving Filgrastim Vs a Filgrastim Biosimilar. Dove Medical Press, 2018.

MLA (9th ed.) Citation

Schwartzberg LS, et al. Incidence of Febrile Neutropenia During Chemotherapy Among Patients with Nonmyeloid Cancer Receiving Filgrastim Vs a Filgrastim Biosimilar. Dove Medical Press, 2018.